Kohlberg recaps CRO Worldwide Clinical Trials

TJC, which has been Worldwide’s sole investor since 2007, retains a meaningful minority equity stake in the CRO.

12 December 2023

You should only be asked to sign in once. Not the case? Click here

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now